EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of a Stability-Indicating Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Determination of Brivaracetam

Yogini N. Rane, Shubham V. Gujar, Momin Sanaurrehman

International Journal of Drug Delivery Technology · 16.07.2026 · 16 (65s)

DOI: 10.25258/ijddt.16.65s.92 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 16.07.2026. Verfasst von Yogini N. Rane und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

.

Zitieren

APA

Rane, Y. N., Gujar, S. V., & Sanaurrehman, M. (2026). Development and Validation of a Stability-Indicating Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Determination of Brivaracetam. International Journal of Drug Delivery Technology, 16(65s). https://doi.org/10.25258/ijddt.16.65s.92

Vancouver

Rane YN, Gujar SV, Sanaurrehman M. Development and Validation of a Stability-Indicating Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Determination of Brivaracetam. International Journal of Drug Delivery Technology. 2026;16(65s). doi:10.25258/ijddt.16.65s.92

BibTeX
@article{Rane2026,
  author = {Rane, Yogini N. and Gujar, Shubham V. and Sanaurrehman, Momin},
  title = {Development and Validation of a Stability-Indicating Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Determination of Brivaracetam},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {65s},
  doi = {10.25258/ijddt.16.65s.92}
}
Kostenlos starten →